{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:33:09Z","timestamp":1787740389677,"version":"build-2784847793"},"reference-count":20,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1620\/tjem.240.1","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T22:12:56Z","timestamp":1471558376000},"page":"1-5","source":"Crossref","is-referenced-by-count":7,"title":["Plasma TGF-&lt;i&gt;\u03b2&lt;\/i&gt;1 Levels Are Elevated in Down Syndrome Infants with Transient Abnormal Myelopoiesis"],"prefix":"10.1620","volume":"240","author":[{"given":"Hajime","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Go","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Momoi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Hosoya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arai, H., Ishida, A., Nakajima, W., Nishinomiya, F., Yamazoe, A. &amp; Takada, G. (1999) Immunohistochemical study on transforming growth factor-beta1 expression in liver fibrosis of Down\u2019s syndrome with transient abnormal myelopoiesis. <i>Hum. Pathol.<\/i>, 30, 474-476.","DOI":"10.1016\/S0046-8177(99)90125-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bessho, K., Mourya, R., Shivakumar, P., Walters, S., Magee, J.C., Rao, M., Jegga, A.G. &amp; Bezerra, J.A. (2014) Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. <i>Hepatology<\/i>, 60, 211-223.","DOI":"10.1002\/hep.27045"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Busciglio, J. &amp; Yankner, B.A. (1995) Apotosis and increased generation of reactive oxygen species in Down\u2019s syndrome neurons in vitro. <i>Nature<\/i>, 378, 776-779.","DOI":"10.1038\/378776a0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Dormann, S., Kruger, M., Hentschel, R., Rasenack, R., Strahm, B., Kontny, U. &amp; Niemeyer, C. (2004) Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome. <i>Eur. J. Pediatr.<\/i>, 163, 374-377.","DOI":"10.1007\/s00431-004-1452-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Gale, G.B., D\u2019Angio, G.J., Uri, A., Chatten, J. &amp; Koop, C.E. (1982) Cancer in neonates: the experience at the Children\u2019s Hospital of Philadelphia. <i>Pediatrics<\/i>, 70, 409-413.","DOI":"10.1542\/peds.70.3.409"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hayasaka, I., Cho, K., Morioka, K., Kaneshi, Y., Akimoto, T., Furuse, Y., Moriichi, A., Iguchi, A., Cho, Y., Minakami, H. &amp; Ariga, T. (2015) Exchange transfusion in patients with Down syndrome and severe and transient leukemia. <i>Pediatr. Int.<\/i>, 57, 620-625.","DOI":"10.1111\/ped.12586"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Hojo, S., Tsukimori, K., Kitade, S., Nakanami, N., Hikino, S., Hara, T. &amp; Wake, N. (2007) Prenatal sonographic findings and hematological abnormalities in fetuses with transient abnormal myelopoiesis with Down syndrome. <i>Prenat. Diagn.<\/i>, 27, 507-511.","DOI":"10.1002\/pd.1718"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hoskote, A., Chessells, J. &amp; Pierce, C. (2002) Transient abnormal myelopoiesis (TAM) causing multiple organ failure. <i>Intensive Care Med.<\/i>, 28, 758-762.","DOI":"10.1007\/s00134-002-1305-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Ishigaki, H., Miyauchi, J., Yokoe, A., Nakayama, M., Yanagi, T., Taga, T., Ohta, S., Itoh, Y. &amp; Ogasawara, K. (2011) Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case. <i>Hum. Pathol.<\/i>, 42, 141-145.","DOI":"10.1016\/j.humpath.2010.06.012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Klusmann, J.H., Creutzig, U., Zimmermann, M., Dworzak, M., Jorch, N., Langebrake, C., Pekrun, A., Macakova-Reinhardt, K. &amp; Reinhardt, D. (2008) Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. <i>Blood<\/i>, 111, 2991-2998.","DOI":"10.1182\/blood-2007-10-118810"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ko, J.W., Lim, S.Y., Chung, K.C., Lim, J.W. &amp; Kim, H. (2014) Reactive oxygen species medidate IL-8 expression in Down syndrome candidate region-1-overexpressed cells. <i>Int. J. Biochem. Cell Biol.<\/i>, 55, 164-170.","DOI":"10.1016\/j.biocel.2014.08.017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kobayashi, Y. (2008) The role of chemokines in neutrophil biology. <i>Front. Biosci.<\/i>, 13, 2400-2407.","DOI":"10.2741\/2853"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Koga, H., Miyako, K., Suga, N., Hidaka, T. &amp; Takahashi, N. (2012) Improving circulatory disturbance in transient abnormal myelopoiesis. <i>J. Pediatr. Hematol. Oncol.<\/i>, 34, e149-151.","DOI":"10.1097\/MPH.0b013e31822bf608"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Miyauchi, J. &amp; Kawaguchi, H. (2014) Fetal liver stromal cells support blast growth in transient abnormal myelopoiesis in Down syndrome through GM-CSF. <i>J. Cell. Biochem.<\/i>, 115, 1176-1186.","DOI":"10.1002\/jcb.24764"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ogawa, J., Kanegane, H., Tsuneyama, K., Kanezaki, R., Futatani, T., Nomura, K., Ishizawa, S., Sasahara, M., Ito, E. &amp; Miyawaki, T. (2008) Platelet-derived growth factor may be associated with fibrosis in a Down syndrome patient with transient myeloproliferative disorder. <i>Eur. J. Haematol.<\/i>, 81, 58-64.","DOI":"10.1111\/j.1600-0609.2008.01061.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Park, M.J., Sotomatsu, M., Ohki, K., Arai, K., Maruyama, K., Kobayashi, T., Nishi, A., Sameshima, K., Takagi, T. &amp; Hayashi, Y. (2014) Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis. <i>Int. J. Hematol.<\/i>, 99, 154-161.","DOI":"10.1007\/s12185-013-1487-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Roy, A., Roberts, I. &amp; Vyas, P. (2012) Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome. <i>Semin. Fetal Neonatal Med.<\/i>, 17, 196-201.","DOI":"10.1016\/j.siny.2012.02.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Shimada, A., Hayashi, Y., Ogasawara, M., Park, M.J., Katoh, M., Minakami, H., Kitoh, T., Kojima, S., Kawa, K. &amp; Kimura, H. (2007) Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders. <i>Leuk. Res.<\/i>, 31, 1199-1203.","DOI":"10.1016\/j.leukres.2006.09.008"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Sugiura, T., Goto, K., Ninchoji, T., Aiba, K., Kouwaki, M., Koyama, N. &amp; Togari, H. (2010) Cytokine profiles before and after exchange transfusion in a neonate with transient myeloproliferative disorder and hepatic fibrosis. <i>J. Pediatr. Hematol. Oncol.<\/i>, 32, e164-166","DOI":"10.1097\/MPH.0b013e3181d74732"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Zimmermann, H.W., Seidler, S., Gassler, N., Nattermann, J., Luedde, T., Trautwein, C. &amp; Tacke, F. (2011) Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. <i>PLoS One<\/i>, 6, e21381","DOI":"10.1371\/journal.pone.0021381"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/240\/1\/240_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T06:11:57Z","timestamp":1657087917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/240\/1\/240_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.240.1","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}